BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 35094384)

  • 21. RBFOX3 Promotes Tumor Growth and Progression via hTERT Signaling and Predicts a Poor Prognosis in Hepatocellular Carcinoma.
    Liu T; Li W; Lu W; Chen M; Luo M; Zhang C; Li Y; Qin G; Shi D; Xiao B; Qiu H; Yu W; Kang L; Kang T; Huang W; Yu X; Wu X; Deng W
    Theranostics; 2017; 7(12):3138-3154. PubMed ID: 28839469
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Full-length telomerase reverse transcriptase messenger RNA is an independent prognostic factor in neuroblastoma.
    Krams M; Hero B; Berthold F; Parwaresch R; Harms D; Rudolph P
    Am J Pathol; 2003 Mar; 162(3):1019-26. PubMed ID: 12598334
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High expression of telomerase is an independent prognostic indicator of poor outcome in hepatoblastoma.
    Hiyama E; Yamaoka H; Matsunaga T; Hayashi Y; Ando H; Suita S; Horie H; Kaneko M; Sasaki F; Hashizume K; Nakagawara A; Ohnuma N; Yokoyama T
    Br J Cancer; 2004 Aug; 91(5):972-9. PubMed ID: 15280920
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum human telomerase reverse transcriptase: a novel biomarker for breast cancer diagnosis.
    Porika M; Tippani R; Bollam SR; Panuganti SD; Thamidala C; Abbagani S
    Int J Clin Oncol; 2011 Dec; 16(6):617-22. PubMed ID: 21526393
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Telomerase reverse transcriptase promotes epithelial-mesenchymal transition and stem cell-like traits in cancer cells.
    Liu Z; Li Q; Li K; Chen L; Li W; Hou M; Liu T; Yang J; Lindvall C; Björkholm M; Jia J; Xu D
    Oncogene; 2013 Sep; 32(36):4203-13. PubMed ID: 23045275
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic significance of telomerase-associated parameters in glioblastoma: effect of patient age.
    Lötsch D; Ghanim B; Laaber M; Wurm G; Weis S; Lenz S; Webersinke G; Pichler J; Berger W; Spiegl-Kreinecker S
    Neuro Oncol; 2013 Apr; 15(4):423-32. PubMed ID: 23393205
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic value of hTERT mRNA expression in surgical samples of lung cancer patients: the European Early Lung Cancer Project.
    Van den Berg RM; Brokx H; Vesin A; Field JK; Brambilla C; Meijer CJ; Sutedja GT; Heideman DA; Postmus PE; Smit EF; Snijders PJ
    Int J Oncol; 2010 Aug; 37(2):455-61. PubMed ID: 20596673
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunohistochemical detection of human telomerase reverse transcriptase (hTERT) and c-kit in serous ovarian carcinoma: a clinicopathologic study.
    Brustmann H
    Gynecol Oncol; 2005 Sep; 98(3):396-402. PubMed ID: 16005054
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CPSF4 activates telomerase reverse transcriptase and predicts poor prognosis in human lung adenocarcinomas.
    Chen W; Qin L; Wang S; Li M; Shi D; Tian Y; Wang J; Fu L; Li Z; Guo W; Yu W; Yuan Y; Kang T; Huang W; Deng W
    Mol Oncol; 2014 May; 8(3):704-16. PubMed ID: 24618080
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A prospective evaluation of the diagnostic and potential prognostic utility of urinary human telomerase reverse transcriptase mRNA in patients with bladder cancer.
    Bowles L; Bialkowska-Hobrzanska H; Bukala B; Nott L; Razvi H
    Can J Urol; 2004 Dec; 11(6):2438-44. PubMed ID: 15636669
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Levels of telomerase catalytic subunit mRNA as a predictor of potential malignancy.
    Hisatomi H; Nagao K; Kanamaru T; Endo H; Tomimatsu M; Hikiji K
    Int J Oncol; 1999 Apr; 14(4):727-32. PubMed ID: 10087321
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quantitation of hTERT gene expression in sporadic breast tumors with a real-time reverse transcription-polymerase chain reaction assay.
    Bièche I; Noguès C; Paradis V; Olivi M; Bedossa P; Lidereau R; Vidaud M
    Clin Cancer Res; 2000 Feb; 6(2):452-9. PubMed ID: 10690523
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Clinical significance of human telomerase reverse transcriptase in patients with colon cancer].
    Li LR; Wan DS; Pan ZZ; Hardingham J; Rieger N; Hewett P; Zhou ZW; Chen G
    Ai Zheng; 2004 Nov; 23(11 Suppl):1502-7. PubMed ID: 15566667
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Akt-mediated phosphorylation increases the binding affinity of hTERT for importin α to promote nuclear translocation.
    Jeong SA; Kim K; Lee JH; Cha JS; Khadka P; Cho HS; Chung IK
    J Cell Sci; 2015 Jun; 128(12):2287-301. PubMed ID: 25999477
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic potential of the telomerase subunit human telomerase reverse transcriptase in tumor tissue and nontumorous mucosa from patients with colorectal carcinoma.
    Gertler R; Rosenberg R; Stricker D; Werner M; Lassmann S; Ulm K; Nekarda H; Siewert JR
    Cancer; 2002 Nov; 95(10):2103-11. PubMed ID: 12412163
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of phosphorylated Akt and hTERT is associated with prognosis of epithelial ovarian carcinoma.
    Lee YK; Chung HH; Kim JW; Song YS; Park NH
    Int J Clin Exp Pathol; 2015; 8(11):14971-6. PubMed ID: 26823830
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Telomerase reactivation is associated with hepatobiliary and pancreatic cancers.
    Sansone V; Le Grazie M; Roselli J; Polvani S; Galli A; Tovoli F; Tarocchi M
    Hepatobiliary Pancreat Dis Int; 2020 Oct; 19(5):420-428. PubMed ID: 32386990
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinicopathologic significance of telomerase activity and hTERT mRNA expression in non-small cell lung cancer.
    Hara H; Yamashita K; Shinada J; Yoshimura H; Kameya T
    Lung Cancer; 2001 Nov; 34(2):219-26. PubMed ID: 11679180
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Constitutive activation of STAT3 signaling regulates hTERT and promotes stem cell-like traits in human breast cancer cells.
    Chung SS; Aroh C; Vadgama JV
    PLoS One; 2013; 8(12):e83971. PubMed ID: 24386318
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The prognostic value of hTERT expression levels in advanced-stage colorectal cancer patients: a comparison between tissue and serum expression.
    Safont MJ; Gil M; Sirera R; Jantus-Lewintre E; Sanmartín E; Gallach S; Caballero C; Del Pozo N; Palomares E; Camps C
    Clin Transl Oncol; 2011 Jun; 13(6):396-400. PubMed ID: 21680300
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.